NCT02516618View on ClinicalTrials.gov

Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

Fasinumab

DRUG

Placebo

Trial Locations (1)

Unknown

Glendale

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT02516618 - Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter